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Introduction
Osteoarthritis (OA) is a chronic, progressive 
musculoskeletal disorder1–3 that mainly affects the 
weight-bearing chondro-synovial joints such as 
knee, hip4 and the upper extremities.5,6 The disease 
affects the ageing population worldwide7,8 leading 
to a high socio-economic burden9 with substantial 
financial consequences.10,11
In a healthy condition, the lubricants present in 
the synovial fluid, such as Hyaluronic acid (HA), 
lubricin12 and the surface-active phospholipids 
(SAPL)13,14 act as shock absorbers protecting the 
joint against compressive damage.15–17 Hyaluronic 
acid (HA) is responsible for the viscoelastic proper-
ties.18
In OA joint diseases, the concentration and mo-
lecular weight of HA decrease16,19 and the synovial 
fluid becomes more abundant, less viscous and re-
duced in elastoviscous properties that may culmi-
nate in a painful condition for the patient.
Viscosupplementation20,21 was identified as an 
effective treatment of OA with a small number of 
adverse effects. Nowadays, it is approved in Eu-
rope/USA for the treatment of pain associated with 
OA of the knee, but considerable controversy about 
its efficacy is still ongoing as evidenced in the 
OARSI treatment guidelines.22 Viscosupplementa-
tion consists in intra-articular, single or repeated, 
injections of HA or HA-based derivatives (HAs). 
Adequate viscoelastic properties are also important 
to restore the articular homeostasis.23 HA or HAs 
increase the elastoviscosity of the intercellular ma-
trix creating a mechanical protective socket that 
surrounds nociceptive nerve endings. This results in 
a decrease in pain and an increase in joint mobility24 
as it has already been demonstrated on animals 
models.25,26
One of the most important drawbacks of HA 
and HAs is the multiple injection therapy due to the 
enzymatic degradation by hyaluronidases in the 
body. High molecular weight products and cross-
linked hydrogels have been developed, but they are 
able to retard the hyaluronidases attack without pre-
venting it.27 Furthermore, inflammatory reactions 
sometimes accompanied by swelling and erythema 
have also been variably reported.28,29
A new derivative similar to HA, but with a bet-
ter behaviour in terms of hardness and stability to-
wards enzymatic degradation30 has been developed 
converting 50 % of the carboxylic groups of car-
boxymethylcellulose (CMC) into amidic groups to 
obtain the amidated carboxymethylcellulose 
(CMCA).31 In vitro results showed that the amida-
tion significantly ameliorated the biocompatibility 
of the material and diminished the cell expression 
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of inflammatory cytokines. CMCA also positively 
influenced osteoblast activity.30 The vegetal origin 
of CMCA potentially avoids the risk of allergic re-
actions due to certain protein components present in 
the HA and Ha-based products injected.
This work involves the development of a novel 
viscosupplementation fluid obtained by blending 
the soluble CMCA polymer (hereinafter indicated 
as CMCAp) with its crosslinked hydrogel deriva-
tive (CMCAg) by crosslinking the residual 50 % 
fraction of CMCAp carboxylic groups.
CMCA-based fluids were investigated to assess 
the rheological properties of the viscosupplement 
fluid during the different processing stages. Both 
continuous and oscillatory shear tests showed that, 
at equal polymer concentration, aqueous CMCAp 
and CMCAg systems exhibit quite different rheo-
logical behaviours, typical of polymer solutions and 
gels, respectively, and hence a wide arc of viscous 
and viscoelastic responses can be obtained by 
blending the two polymers in different proportions. 
The gel fraction (CMCAg/CMCAp ratio) and the 
total polymer concentration of the blend can be ap-
propriately selected in order to ensure an optimal 
combination of viscoelastic properties and flow be-
haviour (injectability) together with an acceptable 
structural recovery after shear.
Materials and methods
Materials
The raw material for CMCA preparation is so-
dium carboxymethylcellulose (average molecular 
weight: 750 kDa, substitution degree 0.8) (CP 
Kelko). It can be functionalized thanks to the pres-
ence of two carboxyl groups in the polymeric unit 
through a water-based synthetic pathway. The car-
boxylic groups are first activated with NHS/EDC 
(N-hydroxysuccinimide purity >97 % (Sigma-Al-
drich); N-(3-dimethylaminopropyl)-N’-ethylcarbo-
diimide hydrochloride purity >99 % (Actim)). Once 
activated, they quickly react with methylamine 
(40 % water solution, Sigma-Aldrich), molar ratio 
of 1:1. The pH of the solution is always kept at 
 4.5–5 adjusting hydrochloric acid. The amide-CMCA 
was then purified in a buffered solution (about pH 
8–8.5 in order to increase the solubility of the poly-
mer) through a Tangential Flow Filtration instru-
ment using a membrane with 100 kDa cut off. The 
obtained solution was separated into two aliquots: 
the former was freeze-dried, the latter was used for 
the crosslinking process.
The amide-CMC polymer is crosslinked by a 
solution of NHS/EDC and a bi-functional group. In 
particular, 1,3-diaminopropane (purity 99.0 %, Sig-
ma-Aldrich) was used as crosslinking agent. The 
molar ratio with the polymer was 0.5:1 to obtain a 
crosslinking degree of about 50 %. The obtained 
hydrogel was purified by repeated rinsing in puri-
fied water and freeze dried. The two freeze-dried 
components, polymer and hydrogel, were milled in 
order to have a controlled cut off, up to 2 mm, that 
were subsequently blended and hydrated in saline 
solution, and eventually filled in syringe and steril-
ized.
Rheological experiments
Rheological characterization was carried out 
with a rotational controlled stress rheometer 
(Rheostress RS150, Haake GmbH, Germany), 
equipped with a cone/plate device (d = 60 mm, an-
gle = 1°) or a parallel plate geometry (d = 35 mm, 
gap = 1 mm) with serrated surfaces in order to avoid 
wall slippage effects. The apparatus was comput-
er-controlled (RheoWin software program) and the 
temperature was kept at 25 ± 0.1 °C (Thermostat 
TC500, Haake GmbH, Germany). The flow proper-
ties were determined applying a logarithmic se-
quence of increasing constant stresses in the range 
1-1000 Pa and measuring the corresponding shear 
rate. Each stress value was kept constant until the 
corresponding time variation of the shear rate satis-
fied the pre-set constraint for steady state attain-
ment, or at most for 90 s.
Oscillatory stress sweep tests were performed 
at 1 Hz in order to individuate the extension of the 
linear viscoelasticity regime. All the frequency 
sweep measurements were performed from 100 to 
0.01 Hz within the linear range.
Recovery tests were performed in order to 
evaluate the structural recovery after the application 
of continuous shear conditions. They were com-
posed of three consecutive segments, alternatively 
under small amplitude oscillatory conditions (at 1 
Hz) and in continuous shear at constant shear rate 
(5 s–1, 180 s). The steady values of G’ and G” at-
tained in the oscillatory segments before and after 
shear flow were compared.
All the experimental tests were done in dupli-
cate or triplicate.
Data treatment and modeling
The experimental viscosity data can be cor-
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where h0 and h∞ represent the zero-shear rate vis-
cosity and the infinite-shear rate viscosity, respec-
tively. In this study, the high shear Newtonian pla-
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teau is beyond the experimental window and, hence, 
h∞ was arbitrarily set equal to 0.89 mPa s, i.e. to the 
water viscosity at 25 °C. The product bp rules the 
slope of the flow curve in the power law region, 
while the critical shear rate gc  marking the onset of 
shear thinning is strictly related to the characteristic 
time a.
The mechanical spectra can be described with 




















where Gi and li are the modulus and the relaxation 
time of the ith Maxwell element, respectively. In or-
der to reduce the problem related to parameter cor-
relation, a scaling criterion was adopted for the re-
laxation time sequence (li+1 = 10 li) and not more 
than 5 Maxwell elements were taken into consider-
ation for data fitting.
Results and discussion
The effects produced by amidation on the rheo-
logical behaviour of CMC solutions appeared to be 
more evident at low shear conditions and higher 
polymer concentrations. Comparing the flow curves 
of CMC and CMCAp solutions at equal concentra-
tion, the zero-shear-rate viscosity diminished after 
amidation and the Newtonian plateau became more 
extended towards higher shear conditions, as it can 
be observed in Fig. 1. Similar rheological effects of 
amidic moieties on carboxymethylcellulose have 
been observed by Barbucci et al.30
A satisfactory data correlation was provided by 
the Carreau-Yasuda equation. Accordingly, the 
above underlined effects can be concisely described 
through the variations of two model parameters: the 
zero shear rate viscosity h0 and the critical shear 
rate gc.
The changes induced by amidation on the lin-
ear viscoelastic behaviour of solutions were coher-
ent with those observed for their flow properties. At 
equal polymer concentration, the mechanical spec-
trum moved towards lower values of both moduli 
and the crossover point shifted to higher frequen-
cies because of the faster relaxation modes. The ex-
ample reported in Fig. 2 regards the 1 % solutions. 
These effects can be evaluated more precisely by 
comparing the relaxation time spectra obtained 
from data correlation with the Maxwell generalized 
model, as illustrated in Fig. 3.
More drastic changes were produced by poly-
mer crosslinking, particularly in linear viscoelastic 
conditions; this can be seen by comparing the re-
F i g .  1  – Steady viscosity curves of aqueous CMC and CMCAp 
solutions at different concentrations (expressed in 
% w/w)
F i g .  2  – Mechanical spectra of aqueous CMC and CMCAp 
1 % w/w solutions
F i g .  3  – Relaxation time spectra of aqueous CMC and CMCAp 
1 % w/w solutions derived from data correlation 
with the Maxwell generalized model
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sponses of both of CMCAp and CMCAg systems 
with the same concentration of soluble and cross-
linked polymer (2.5 % for systems represented in 
Figs. 4a and 4b, respectively).
Stress sweep tests showed that both viscoelas-
tic moduli of the CMCAg system were markedly 
higher, and in the nonlinear region, their profiles 
were different from those of the corresponding CM-
CAp solutions (Fig. 4a). For the latter systems, the 
transition from linear to nonlinear regime is de-
scribed by monotonic decrease of both moduli. This 
behaviour is usually observed in ordinary polymeric 
solutions and labelled as type I according to the 
classification of LAOS responses.34 Conversely, in 
the case of CMCAg systems, the storage modulus 
decreased monotonically with increasing strain 
whereas a weak overshoot appeared in the G’’ pro-
file. Such a pattern (Type III) is typical of weakly 
structured fluids (physical gels or colloidal disper-
sions). For CMCAg systems, the critical strain 
marking the borderline of the linear viscoelastic re-
gime became sensibly lower (two orders of magni-
tude or more) than for CMCAp solutions.
The quite different profiles of the mechanical 
spectra of CMCAp and CMCAg systems reflect the 
neat changes produced by crosslinking in linear vis-
coelastic properties and relaxation modes, thus evi-
dencing the structural transition from solution to 
physical gel (Fig. 4b). In the experimental window 
explored, the behaviour of the CMCAp solution 
was characterized by a prevailing viscous compo-
nent (G”>G’) and short relaxation times, as it can 
be deduced by the crossover frequency. In the case 
of the crosslinked polymer, the storage modulus 
curve is placed clearly above G” values, and reach-
es a plateau condition at low frequencies, where the 
divergence from the linear viscoelastic responses of 
CMCAp is quite evident.
Studying the steady flow properties, we found 
that CMCAg systems exhibited much more pro-
nounced shear thinning than CMCAp solutions, ow-
ing to their different structural conditions and 
shear-induced mechanisms. CMCAg systems be-
have as dispersions of gel microdomains, which 
may undergo significant deformations and spatial 
rearrangements with increasing shear rate.
Looking at the problems connected to the de-
velopment of a novel polymeric fluid for visco-
supplementation treatment, the first decisive step 
concerns its formulation in relation to the structural 
and rheological properties that the fluid must pos-
sess and exhibit. In particular, it should be easily 
injectable and display appropriate viscoelastic re-
sponses ‘in situ’ in the various kinematic condi-
tions experienced by articular joints. Furthermore, 
an adequate resistance to enzymatic degradation 
and mechanical solicitations for prolonged times 
should be ensured. Blending CMCAp solutions 
and CMCAg microgel dispersions it is possible to 
finely adjust the composition ratio and the total 
polymer concentration in order to modulate the 
structural features and rheological properties of 
both systems.
The following figures illustrate how the rheo-
logical properties of CMCAp-CMCAg blends 
changed with increasing gel fraction at equal total 
polymer concentration. The steady viscosity strong-
ly increased at low shear rates, while its change was 
almost negligible at high shear rates. As the gel 
fraction increased, the shear thinning character of 
the flow behaviour became more and more marked, 
being ruled by the level and extension of the New-
tonian plateau (Fig. 5).
The experimental data can be correlated quite 
satisfactorily with the Carreau-Yasuda equation. 
The effects of increasing gel fraction fg on viscous 
F i g .  4  – Viscoelastic responses of 2.5 % CMCAp and 2.5 % 
CMCAg systems; a) storage and loss moduli vs strain (from 
stress sweep test); b) mechanical spectra (from frequency 
sweep test)
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properties of CMCAp-CMCAg blends can be rea-
sonably described through the only variations of the 
zero-shear rate viscosity h0 and the critical shear 
rate gc, marking the border of the Newtonian plateau 
(Fig. 6). Thus, it can be noted that the most signifi-
cant changes occurred in the fg interval between 0.2 
and 0.3, where gc  drops significantly, and the rate of 
h0 increase became slower. At higher fg values, the 
increasing concentration of gel microdomains in the 
whole polymeric phase resulted only in an exponen-
tial h0 increase with no appreciable effect on the 
critical shear rate.
Similarly, the linear viscoelastic behaviour of 
the blend significantly changed with increasing gel 
fraction. To clarify, the graphical representation re-
ported in Fig. 7 involves only a partial subset of the 
mechanical spectra experimentally determined. As 
may be observed, the increasing gel fraction fg led 
to an increase in the elastic character of the visco-
elastic response, which was more pronounced at 
lower frequencies where the storage modulus in-
creased more markedly than the viscous compo-
nent. Consequently, a progressive change was ob-
served in the shape of the mechanical spectrum, 
passing from CMCAp solution to CMCAg system. 
According to the Winter-Chambon criterion35,36, the 
sol-gel transition could be located near fg = 0.3, 
since the traces of G’ and G’’ of system 7 were 
 almost coincident and obey the same scaling law 
(G’    G’’    wn, n    0.45) in the experimentally ex-
plored frequency window.
The generalized Maxwell model provides a sat-
isfactory data correlation and, consequently, the re-
sulting relaxation time spectra can be profitably 
used for analysing the blending effects on the linear 
viscoelastic responses in the place of the mechani-
cal spectra (Fig. 8). As the CMCAg content of the 
polymeric phase increased, the relative weight of 
the slowest relaxation modes became more import-
F i g .  5  – Steady viscosity curves of 2.5 % CMCAp-CMCAg 
blends at different gel fractions (1 represents the polymer/gel 
ratio of 0/10; 0 represents a polymer/gel ratio of 10/0)
F i g .  6  – Zero-shear rate viscosity and critical shear rate vs 
gel fraction in 2.5 % CMCAp-CMCAg blends
F i g .  7  – Mechanical spectra of 2.5 % CMCAp-CMCAg 
blends at different gel fractions (0 represents the polymer/gel 
ratio of 10/0; 1 represents a polymer/gel ratio of 0/10)
F i g .  8  – Relaxation time spectra derived from data correlation 
with the generalized Maxwell model for 2.5 % CMCAp-CMCAg 
blends (1 represents the polymer/gel ratio of 0/10, 0 represents 
a polymer/gel ratio of 10/0)
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ant owing to the increasing contribution of gel mi-
crodomains towards a structural state close to jam-
ming.
The analysis of the reversibility of linear visco-
elastic responses (G’, G’’) can be particularly useful 
in view of the development of a novel viscosupple-
ment, which must be injected, and hence undergoes 
short but intense shear conditions in the application 
phase. Recovery tests performed on CMCAp-CMCAg 
blends showed that the viscoelastic behaviour was 
completely reversible for CMCAp solution, since 
the values of G’ and G” before and after shear flow 
were shown to be equal. On the other hand, only a 
partial recovery was attained for CMCAg system 
along the time segment following the application of 
a constant shear rate. The viscoelastic recovery de-
creased with increasing gel fraction.
Investigations were also carried out on the de-
velopment of a pilot production process and evalu-
ations were made on the potential effect of each 
processing step on the blend’s final properties. 
Standard production implies a set of consecutive 
steps to obtain both components of the polymeric 
blend: CMC solubilization, CMC functionalization 
in order to obtain CMCA, purification of CMCA, 
concentration and freeze-drying of the polymer, 
crosslinking of the CMCA, purification of the ob-
tained hydrogel, concentration and freeze-drying of 
the hydrogel. The final steps cover rehydration in 
saline solution, polymer and gel blending, filling in 
syringe and sterilization.
Among the several steps of the manufactur-
ing process, some of them can strongly affect the 
elastoviscosity of the polymer blend. It has been 
 observed that freeze drying, homogenization in 
 saline solution and filling in syringes can produce 
a drastic decrease in loss and storage moduli in 
both soluble and crosslinked CMCA. Moreover, 
 because viscosupplements are classified as phar-
maceutical products or medical devices, an essen-
tial requirement for CMCA blends is represent-
ed by their capability to resist the sterilization 
process.
Several techniques based on chemical agents 
(EtO, plasma) or physical processes (heating, b or γ 
radiation) are widely used for sterilization in the 
pharmaceutical and medical devices industries. 
Among them, the most suitable and promising 
method in terms of efficacy and compatibility with 
solution or emulsions is represented by steam or 
moist heat. Conversely, it is known that heat induc-
es degradation of CMC gels and polymer solutions37 
and at high temperatures CMC degrades and perma-
nently reduces in viscosity. Therefore, a rheological 
investigation has been dedicated to evaluate the po-
tential degradation of CMCA blends during the 
manufacturing process, in particular that caused by 
steam sterilization.
Typical moist-heat sterilization cycles, based 
on exposition to temperature of 121 °C for 15’ have 
been applied, and the mechanical spectra obtained 
for unsterile and sterile blends of equal total poly-
mer concentration and gel fraction have been com-
pared. As highlighted in Fig. 9, it can be seen that 
steam sterilization induced a loss of both elastic and 
viscous moduli due to the polymer degradation, and 
hence a reduction in the main properties of the de-
vice.
Consequently, the initial formulation must be 
readjusted in terms of total polymer concentration 
and gel fraction in order to compensate the negative 
effects produced by the manufacturing process on 
the rheological behaviour of the blend and to re-
store a correct balance among viscoelasticity, stabil-
ity and easy injectability. In fact rheological proper-
ties of numerous viscosupplements available on the 
market cover a wide spectrum of values and some-
times they are quite different from those peculiar to 
healthy synovial fluids.20,38–40
This suggests that the main requirements for 
such devices are represented by their viscoelastic 
properties in order to exhibit a proper response to 
the stress conditions within synovial joints, together 
with their capability to be easily injected through an 
18-20 G needle. It is also acknowledged that the 
values of the linear viscoelastic moduli measured at 
0.5 and 2.5 Hz can represent a suitable way to eval-
uate how synovial fluid and viscosupplements react 
to walking and running conditions, respectively.20,41 
Accordingly, they can serve to discriminate the be-
haviours of synovial fluids in normal and patholog-
ical conditions, as well as to assess the effects of 
viscosupplementation therapies.39,40,42 The experi-
mental values obtained for a series of commercial 
viscosupplements are reported in Fig. 10a. The 
F i g .  9  – Reduction ratio of viscoelastic moduli between unster-
ile and sterile 2.5 % CMCAp-CMCAg blends vs gel 
fraction at two reference frequencies (0.5 and 2.5 Hz)
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quite large interval covered by both moduli at both 
frequencies is strictly related to the different me-
chanical spectra displayed by the systems consid-
ered, spanning from those typical of ordinary poly-
meric solutions to classical gel behaviours. Similar 
differences can also be found among novel systems 
proposed as candidates for viscosupplementa-
tion.40,42–45
Tests performed on blends with different gel 
fractions have shown that an acceptable structural 
recovery after continuous shear application (more 
than 80–90 %) is attained when the gel fraction is 
lower than 50 %. Thus, the 6/4 CMCAp/CMCAg 
blend has been provisionally selected for the final 
investigation addressed to individuate the most 
 suitable total polymer concentration, apt to compen-
sate the loss in mechanical properties occurring 
during processing and sterilization. The viscoelastic 
moduli of three 6/4 CMCAp/CMCAg blends with 
different total polymer concentrations are compared 
with those of two commercial products in Fig. 10b, 
while Fig. 10c reports the viscosity values of the 
same systems at three different shear rates. From 
both figures, it can be inferred that the 3.61 w/w 
concentration provides adequate viscoelastic prop-
erties, which are combined with a proper injecta-
bility.
Conclusions
Blends with tailored viscoelastic properties can 
be obtained from CMCA in the form of polymer 
solutions and crosslinked hydrogels.
More specifically, the entire range between 
10/0 and 0/10 of polymer/hydrogel ratio has been 
investigated, and the 5/5-6/4-7/3 polymer/hydrogel 
compositions seem to create a behaviour very close 
to the main characteristics of an HA-based product 
for viscosupplementation.
This study has demonstrated the importance of 
both polymer and hydrogel form in blends, because, 
if singularly used, (10/0 and 0/10 of polymer/hydro-
gel samples), they are unable to preserve both stor-
age and loss moduli.
Properties, such as lubrication and shock ab-
sorbing, together with an adequate resistance to 
processing and steam sterilization, can be assured 
by using a concentration of 3.61 % w/w.
The possibility to formulate CMCA in several 
polymer/hydrogel blends and in different concentra-
tions, together with its biocompatibility and its slow 
enzymatic degradation, should be considered as a 
promising alternative to HA for the design of new 
products for viscosupplementation.
F i g .  1 0  – a: Viscoelastic moduli (at 0.5 and 2.5 Hz) of the 
commercial viscosupplements listed below. b: Viscoelastic moduli 
(at 0.5 and 2.5 Hz) of the 6/4 CMCAp/CMCAg blends at 2.5 %, 
3 % and 3.61 % w/w concentrations compared with those of two 
commercial products (Orthovisc and Monovisc). c: Viscosity 
values (at 0.1, 10 and 1000 s–1) of the 6/4 CMCAp/CMCAg blends 
at 2.5 %, 3 % and 3.61 % w/w concentrations compared with 
those of two commercial products (Orthovisc and Monovisc).
Commercial viscosupplement
Suplasyn (Mylan N.V., UK), non-heat degraded highly purified sodium 
hyaluronate (500 to 730 kDa), measured values, ref. 39.; Hyalubrix (Fidia 
farmaceutici S.p.A., Italy), sodium hyaluronate (1300 to 3600 kDa), from 
bacteria fermentation, estimated values, ref. 40.; Orthovisc (Anika Ther-
apeutics MA, USA), highly purified sodium hyaluronate in physiologic 
saline, measured values, ref. 39.; Monovisc (Anika Therapeutics MA, 
USA) highly purified, partially crosslinked sodium hyaluronate in a phos-
phate buffered saline solution, estimated values, ref. 40.; Noltrex (JSC 
“Research center “Bioform”, Russia), synthetic polyacrylamide hydrogel 
with silver ions, measured values in our laboratory; Hymovis (Fidia far-
maceutici S.p.A., Italy), partially hydrophobized derivative of hyaluronic 
acid, estimated values, ref. 40.; Synvisc (Hylan G-F 20) (Genzyme Bio-
surgery, USA). blend 80/20 of Hylan A (high molecular weight hyaluron-
ic acid) and Hylan B (crosslinked hyaluronic acid), measured values, ref. 
39.: Durolane (Bioventus, USA), crosslinked hyaluronic acid, measured 
values in our laboratory.; Fermathron (Hyaltech Ltd. UK), sodium hyal-
uronate (1300 to 3600 kDa) in a phosphate buffered saline solution, from 
bacterial fermentation, measured values in our laboratory.
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